- €7.65bn
- €18.65bn
- €7.52bn
Brief: Grifols To Pay Interim Dividend Of 0.15 Eur/Shr On Aug 13
Brief: Grifols H1 Net Profit At 176.8 Mln Euros
Brief: Grifols To Build Plant In Spain To Double Its Plasma Fractionation Capacity
Europe Research Roundup: Azelis, Barratt Redrow, ArcelorMittal
Media: Grifols case shows it paid family-linked entity more for plasma - Bloomberg news
Brief: Grifols Says Positive Fibrinogen Phase 3 Trial Results Published
Spanish stocks - Factors to watch on June 12
Brief: Grifols Says Delisting Offer Accepted By 416,922 Ordinary Shares Of Biotest
Spanish stocks - Factors to watch on June 6
Spanish stocks - Factors to watch on June 3
Brief: Mason Capital Management To Support Grifols Recommended Director Slate At Upcoming Ordinary General Meeting
US court finds enough evidence to proceed with Grifols lawsuit against Gotham City (updated)
US court finds enough evidence to proceed with Grifols lawsuit against Gotham City
Brief: Grifols Says US Court Denies Gotham City Research's Motion To Dismiss Lawsuit Filed By Grifols
Spanish stocks - Factors to watch on May 30
Spanish stocks - Factors to watch on May 23
Brief: Moody's Ratings Upgrades Grifols' Rating To B2, Outlook Remains Positive
Brief: Grifols Gets FDA Approval To Start Phase 2 Trial With Immunoglobulin Eye Drops
Grifols rises after Q1 beat